The Cineworld share price surges. Should I buy the stock?

The Cineworld share price is surging, making it the best-performing stock in the FTSE 250 so far this year. Is it now a buy for my portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The Cineworld (LSE: CINE) share price is having a storming start to 2022. Already this year, the stock is up 39% as I write today. However, to throw cold water on the fire, over one year the share price is still down by 35%. Ouch.

Does the recent surge mean the cinema chain is back on track? Or is it a false dawn and not worth me buying the shares? Let’s take a closer look.

The bull case

It seems like the worst of the pandemic may be over. Thankfully, Omicron didn’t require a lockdown like previous strains of Covid, even though case numbers spiked. Unless there’s another more severe mutation, I can’t see there being any further lockdown either. This will clear a huge potential risk from Cineworld’s business, and likely lead to raised profit guidance in the months ahead.

Recent trading supports this view. In an update from Cineworld released just this week, the company said attendances have steadily grown through the second half of 2021. Revenue has also grown in line with the increases in attendance. The improved revenue profile together with cost controls has resulted in positive cash flow in the fourth quarter of 2021 too.

The bear case

One of the biggest risks to the shares is the considerable debt on Cineworld’s balance sheet. According to the last published accounts, the company had $8.4bn of net debt. Considering that Cineworld’s market value is only £610m, and is currently loss-making, this borrowing is highly significant. It’ll be crucial for Cineworld to maintain its positive cash flow in the months ahead so it can service this debt load.

There’s another big uncertainty on the horizon for Cineworld. It’s been ordered to pay C$1.23bn by a Canadian court ruling due to a breach of an agreement with Cineplex. Before the pandemic, Cineworld had agreed to acquire Cineplex, but pulled out of the deal when it had to close its cinemas during lockdown. Cineworld is appealing the ruling, but it still leaves a dark cloud over the business for now.

Should I buy at this Cineworld share price?

There’s no doubt that Cineworld has had a very difficult period through the pandemic. However, I’m most interested in the potential for recovery if I buy its shares today. Earnings are expected to rebound into positive territory in 2022. Then, all going well, City analysts are expecting huge growth in earnings again in 2023. If this plays out, the Cineworld share price is valued on a price-to-earnings ratio for 2023 of only 5.

However, there’s a lot for the company to deal with before then. For a start, the company has to stay cash flow positive so that it can pay interest on that huge debt pile. Then, the looming court ruling could also shatter Cineworld’s balance sheet if it ends up having to pay the damages after the appeal.

So, for now, there are just too many risks for me to want to buy the shares. The valuation looks cheap, but I think it takes into account these significant risks ahead. I’ll revisit the company once the outlook on the court ruling is clearer.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Dan Appleby owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »